Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status

2014 ◽  
Vol 99 (4) ◽  
pp. 513-518 ◽  
Author(s):  
Chika Kawajiri ◽  
Hiroaki Tanaka ◽  
Shinichiro Hashimoto ◽  
Yusuke Takeda ◽  
Shio Sakai ◽  
...  
Keyword(s):  
Acute Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Successful Treatment ◽  
Second Generation ◽  
Kinase Inhibitors ◽  
Philadelphia Chromosome ◽  
Mutation Status ◽  
Mixed Phenotype Acute Leukemia ◽  
Mixed Phenotype

The landscape of BCR‐ABL mutations in patients with Philadelphia chromosome‐positive leukaemias in the era of second‐generation tyrosine kinase inhibitors

2020 ◽  
Vol 38 (3) ◽  
pp. 390-398
Author(s):  
Sheng‐Hsuan Chien ◽  
Hsueng‐Mei Liu ◽  
Po‐Ming Chen ◽  
Po‐Shen Ko ◽  
Jeong‐Shi Lin ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Second Generation ◽  
Kinase Inhibitors ◽  
Philadelphia Chromosome ◽  
Philadelphia Chromosome Positive
Sign in / Sign up

Export Citation Format

Share Document